| P/E (FY) | — | Sales (TTM) | $31.1M |
| Earnings (TTM) | -$2.5M | ROE | — |
| Net Margin | −7.70% | ROIC | — |
| Debt / Equity | — | TD / EBITDA | 5.69 |
| EPS Growth 3Y | — | Sales Growth 3Y | 1.33% |
| Market Cap | $27.3M | Trading Days | 5278 |
| 52W High | 5.43 |
| 52W Low | 2.72 |
| % Off High | −37.75% |
| YTD | −1.74% | 1Y | −31.30% |
| 3Y | −33.64% | 5Y | −55.60% |
| 10Y | 5.44% | Since incept. (ann.) | 1.41% |
Umbilical Cord Blood And Cord Tissue Stem Cell Service 99% · Public Cord Blood Banking 0% · Prepacytecb 0%
| Ann. Volatility (1Y) | 64.17% | Ann. Volatility (3Y) | 63.82% |
| Sharpe (1Y) | −0.26 | Sharpe (3Y) | 0.10 |
| Max Drawdown (1Y) | −45.57% | Max Drawdown (3Y) | −66.25% |
| Beta (3Y, vs SPY) | 0.65 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| MRAI | Marpai, Inc. | $53.1M | — |
| MGRX | MANGOCEUTICALS, INC. | $9.5M | — |
| PARK | Park Dental Partners, Inc. | $89.1M | — |
| BRTX | BioRestorative Therapies, Inc. | $6.8M | — |
| VMD | VIEMED HEALTHCARE, INC. | $457.0M | 32.2 |
| PGNY | Progyny, Inc. | $2.41B | 47.3 |
| SHC | Sotera Health Co | $5.06B | 65.8 |
| DVA | DAVITA INC. | $15.37B | 24.3 |
| AGL | agilon health, inc. | $41.04B | — |
| FMS | Fresenius Medical Care AG | — | — |
| FOFA | FAMILY OFFICE OF AMERICA, INC. | $27.3M | — |
| ATNM |
| Actinium Pharmaceuticals, Inc. |
| $27.2M |
| — |
